Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation.

Ferrari, Samuele; Vavassori, Valentina; Canarutto, Daniele; Jacob, Aurelien; Castiello, Maria Carmina; Javed, Attya Omer; Genovese, Pietro

Ferrari, Samuele; Vavassori, Valentina; Canarutto, Daniele; Jacob, Aurelien; Castiello, Maria Carmina; Javed, Attya Omer; Genovese, Pietro.

Afiliação

Ferrari S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Vavassori V; PhD course in Molecular Medicine, Vita-Salute San Raffele University, Milan, Italy.
Canarutto D; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Jacob A; PhD course in Molecular Medicine, Vita-Salute San Raffele University, Milan, Italy.
Castiello MC; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Javed AO; PhD course in Molecular Medicine, Vita-Salute San Raffele University, Milan, Italy.
Genovese P; Pediatric Immunohematology and Bone Marrow Transplantation Unit, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy.

Front Genome Ed ; 3: 618378, 2021.

Article em En | MEDLINE | ID: mdl-34713250

Palavras-chave

CRISPR/Cas; gene editing; gene therapy; hematological diseases; hematopoietic stem cell

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Genome Ed Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google